Sage for Health & Longevity - Quick Reference Sheet

Sage for Health & Longevity

Created on 09/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Sage is a culinary herb with drug-like activity. One dose of standardized leaf extract briefly sharpens memory and attention; daily extract improves blood sugar and blood fats, though almost all from one research group. Menopausal hot flush relief is plausible; combined results are unstable and the strongest trials were company-funded. Leaf preparations are well tolerated; concentrated oil can cause convulsions. (Full Review)

Protocol

Standard metabolic protocol
500 mg, three times daily
Salvia officinalis leaf extract capsules with meals, for 2 to 3 months
Standard cognitive protocol
300 to 600 mg, single dose
Standardized leaf extract, or 25 to 50 µL Salvia lavandulaefolia essential oil, on the day performance matters
Standard menopausal protocol
One tablet daily
Fresh-leaf ethanolic extract, or 100 mg of dried extract three times daily
Time to effect
Cognitive effects
1 to 4 hours
After a single dose; effects fade by 6 hours
Metabolic changes
2 to 3 months
Measured at 2 and 3 months; no earlier timepoint reported
Vasomotor benefit
Week 3 to week 8
Significant around week 3, peaking near week 8

Benefits

Contraindications
  • Epilepsy or any prior seizure, controlled or not (essential oil, high-thujone alcoholic extracts)
  • Sage essential oil with anticonvulsants (levetiracetam, lamotrigine, valproate)
  • Pregnancy at any gestational age; lactation where maintaining milk supply matters
  • Estrogen-receptor-positive breast, endometrial or ovarian cancer, or tamoxifen or an aromatase inhibitor
  • Hepatic impairment of Child-Pugh Class B or C
  • Children under 12 years (essential-oil preparations, any concentration)
  • Known allergy to the mint family, Lamiaceae (basil, oregano, mint, rosemary, thyme)
  • Within 2 weeks of elective surgery
Key Interactions
  • Insulin and sulfonylureas (glimepiride, glyburide, gliclazide)
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
  • Sedatives acting on GABA-A (benzodiazepines, zopiclone, phenobarbital)
  • Statins (atorvastatin, rosuvastatin, simvastatin)
  • Warfarin and other vitamin K antagonists
  • Over-the-counter sore-throat products (chlorhexidine, lidocaine, benzydamine)
  • Over-the-counter anticholinergics (diphenhydramine, dimenhydrinate, oxybutynin)
  • Cholinesterase-inhibiting supplements (huperzine A, Bacopa monnieri, Melissa officinalis)
  • Supplements with additive glucose- and lipid-lowering effects (berberine, cinnamon extract, red yeast rice)
  • Other interventions (very-low-carbohydrate diets, prolonged fasting, high-volume endurance training)

Risk & Side Effects

  • High: Additive blood-glucose lowering
  • Medium: Local irritation of the mouth and throat
  • Low: Seizures from thujone-rich sage oil; allergic contact dermatitis; additive blood-pressure lowering
  • Speculative: Estrogen-receptor activation in hormone-sensitive conditions; suppression of milk production; blunting of sedatives that act through GABA

Monitoring

Marker Target Why
Fasting glucose 75–85 mg/dL Primary target; also detects an excessive drop
Glycated hemoglobin 4.8–5.2% Confirms the glucose change is sustained, not a single reading
Fasting lipid panel Triglycerides under 80 mg/dL; HDL above 55 mg/dL (men) or 65 (women); triglyceride-to-HDL ratio under 2 Sage's most consistently replicated metabolic effect
Fasting insulin and HOMA-IR Insulin under 5 µIU/mL; HOMA-IR under 1.5 Detects the insulin-sensitivity effect before glucose moves
ALT and AST 10–26 U/L each Herb safety screen; sage trials showed no change, so any rise is unexpected
Creatinine with eGFR eGFR above 90 mL/min/1.73 m² Confirms unchanged kidney handling, as trials reported
Blood pressure, seated and standing Under 120/80 mmHg seated, with no fall greater than 20/10 mmHg on standing Both a fall and a rise have been reported, so direction is unpredictable
Thyroid-stimulating hormone 1.0–2.0 mIU/L Excludes a thyroid cause of the sweating and fatigue sage is taken for
Cognitive test score No established target; track the change from the individual's own baseline instead The only way to judge the cognitive claim personally rather than statistically

Cadence: Baseline panel before starting; blood pressure and symptoms weekly for the first four weeks; metabolic and liver panel repeated at 8 to 12 weeks, then every 6 to 12 months while use continues; cognition retested at 12 weeks with an alternate test version.

Qualitative Assessment

  • Word-finding and recall in conversation: everyday correlate of delayed recall
  • Sustained attention through the afternoon: largest 1 to 4 hours post-dose
  • Night-sweat frequency and sleep continuity: a simple nightly count
  • Throat comfort and oral tissue condition: intended local effect versus documented irritation
  • Digestive tolerance and dry mouth: earliest sign the dose exceeds individual tolerance